Edgewise Therapeutics, Inc.

US$45.04As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EWTXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR 5.99%
Div yield —
ROE 92.15%
Biotechnology
Beta (5Y) 0.40
PE TTM 5.187
TSR TTM 146.39%
Mkt cap US$4.931B
ROIC (12.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$56
25.38%
(19.04%)
Hold 4|10|10|10|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.56
0.56
0.61
0.59
7.37%
12.91%
24.00%
15.80%
Revenue$M
540.0
549.4
562.1
582.3
15.86%
11.24%
10.49%
11.67%
Peers (US$4.931B)
Cap (US$)
PE
5.040B
—
4.882B
29.91x
Capital
TTM
5Y
10Y
Leveragex
1.877
0.522
0.474
EBIT/Intx
1.470
0.160
0.163
Own earn%
(106.09)
(1.61)
14.38
Sh yield%
30.73
33.74
35.11
Owners
Insiders/Inst%
12.91
45.20
Short interest%
4.28
SBC / revenue%
5.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
28–34
$1 testx
0.0
Incr. ROIC%
3